Skip to main content

Maria Pinyol i Sarrias

I am a pediatric resident pysician at Hospital Infantil Vall d'Hebron, specializing in Paediatrics. I graduated in 2021 with a degree in Medicine from the Universtitat Autònoma de Barcelona combining my studies with international experiences that have broadened my medical and cultural perspective. During my residency, I am complementing my clinical training with research activity at the Vall d’Hebron Research Institute (VHIR).

Institutions of which they are part

Research technician
Infection and immunity in pediatric patients
Vall Hebron Institut de Recerca
Metge/ssa resident
Paediatrics
Children's Hospital and Woman's Hospital

Maria Pinyol i Sarrias

Institutions of which they are part

Research technician
Infection and immunity in pediatric patients
Vall Hebron Institut de Recerca
Metge/ssa resident
Paediatrics
Children's Hospital and Woman's Hospital

I am a pediatric resident pysician at Hospital Infantil Vall d'Hebron, specializing in Paediatrics. I graduated in 2021 with a degree in Medicine from the Universtitat Autònoma de Barcelona combining my studies with international experiences that have broadened my medical and cultural perspective. During my residency, I am complementing my clinical training with research activity at the Vall d’Hebron Research Institute (VHIR).

Graduated in Medicine from the Autonomous University of Barcelona in 2021 and currently a resident in Pediatrics and specific areas at Vall d'Hebron Children's Hospital, with a special interest in infectious diseases and pediatric immunodeficiencies. Since 2024, I have been part of the Paediatric Infection and Immunity Research Group at the Vall d'Hebron Research Institute (VHIR).

Projects

PFIZER_Isavuconazole use and pharmacokinetics in pediatric patients under ECMO support

IP: Natalia Ana Mendoza Palomar
Collaborators: Maria Pinyol i Sarrias
Funding agency: Pfizer Inc
Funding: 25653
Reference: PFIZER_A.MENDOZA_IMI2025
Duration: 01/01/2026 - 31/10/2026

Related news

The appointments were announced at the society congress, where seven studies from Vall d’Hebron were also presented.

Dr. Natalia Mendoza and Dr. Manuel Analís Bernal have received the Young Researcher and the Best Research Article by a Resident Awards, respectively.

The vaccine activates both antibody production and the T-cell response, maintaining, for at least one year, a higher immune response than before vaccination.

Related professionals

Jesús Francisco Lopez Lozano

Jesús Francisco Lopez Lozano

Predoctoral researcher
General Surgery
Read more
M Jesus Arevalo Navines

M Jesus Arevalo Navines

Postdoctoral researcher
Clinical Neuroimmunology
Read more
Elisabet Miro Casas

Elisabet Miro Casas

Research technician
Cardiovascular Diseases
Read more
Mireia Andres Villarreal

Mireia Andres Villarreal

Predoctoral researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.